Added to YB: 2020-09-22
Pitch date: 2020-09-22
CRSP:US [bullish]
CRISPR Therapeutics AG
-38.39%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.
Market Cap
$5.1B
Pitch Price
$88.69
Price Target
N/A
Dividend
N/A
EV/EBITDA
-6.57
P/E
-8.27
EV/Sales
959.56
Sector
Biotechnology
Category
N/A
Show full summary:
CRISPR Therapeutics AG CRSP:US
A summary for this pitch has not been created yet.
Read full article (0 min)